Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2010
04/06/2010US7691846 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 1-(3-amino-1,2-benzisoxazol-5-yl)-5-{[5-(2-oxo-1-piperidinyl)-2,3-dihydro-1H-indol-1-yl]carbonyl}-1H-pyrazole-3-carboxamide; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis
04/06/2010US7691844 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure
04/06/2010US7691841 Azetidine derivatives as CCR-3 receptor antagonist
04/06/2010US7691837 e.g. 1-{[1,5-bis(4-cholorophenyl)-2-methylpyrrol-3-yl]methyl}-4-(4-fluoro-phenyl)piperazine; Mycobacterium tuberculosis, drug resistant Mycobacterium tuberculosis, Mycobacterium avium-intracellulare complex, Mycobacterium fortuitum or Mycobacterium kansasi
04/06/2010US7691785 Pyridine-3-ketone compound; plant growth controllers
04/06/2010CA2566108C Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
04/06/2010CA2455181C Benzimidazo[4,5-f]isoquinolinone derivatives
04/06/2010CA2453383C Piperidine derivatives as nmda receptor antagonists
04/06/2010CA2361057C Quinoline derivatives and quinazoline derivatives
04/06/2010CA2252536C Ethylene derivatives and pesticides containing said derivatives
04/01/2010WO2010037129A1 Quinazolinone, quinolone and related analogs as sirtuin modulators
04/01/2010WO2010037059A2 Heteroaryl antagonists of prostaglandin d2 receptors
04/01/2010WO2010037054A2 Heteroaryl antagonists of prostaglandin d2 receptors
04/01/2010WO2010036873A1 2-[1H-Benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
04/01/2010WO2010036814A1 Selective seprase inhibitors
04/01/2010WO2010036629A2 Fused multicyclic compounds as protein kinase inhibitors
04/01/2010WO2010036613A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
04/01/2010WO2010036553A1 Fungicidal pyridazines
04/01/2010WO2010036329A2 Process for making quinolone compounds
04/01/2010WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient
04/01/2010WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same
04/01/2010WO2010035283A2 Novel compounds for producing substituted sulfoxides, process for producing the same and use thereof
04/01/2010WO2010034838A2 New chemical compounds
04/01/2010WO2010034797A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents
04/01/2010WO2010034796A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents
04/01/2010WO2010034671A1 Pyrine or pyrazine derivatives for treating hcv
04/01/2010WO2010034657A1 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
04/01/2010WO2010034649A1 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as fxr modulators against dyslipidemia and related diseases
04/01/2010WO2010017545A3 Triazole compounds that modulate hsp90 activity
04/01/2010WO2010017240A3 Aurora kinase modulators and methods of use
04/01/2010WO2010011626A3 Pyridinyl modulators of ϒ-secretase
04/01/2010WO2010006904A3 Crystalline forms of rabeprazole sodium
04/01/2010WO2010002655A3 Pyrimidine derivatives as kinase inhibitors
04/01/2010WO2009131669A3 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/01/2010WO2009124734A3 Substituted sulfonamide derivatives
04/01/2010US20100081825 1-naphthyl alkylpiperidine derivative
04/01/2010US20100081812 Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders
04/01/2010US20100081692 Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma
04/01/2010US20100081691 Multicyclic compounds and methods of their use
04/01/2010US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter
04/01/2010US20100081679 Diaminopyrimidines as fungicides
04/01/2010US20100081677 Heteroarylamide pyrimidone derivatives
04/01/2010US20100081675 Fused multicyclic compounds as protein kinase inhibitors
04/01/2010US20100081673 Heteroaryl antagonists of prostaglandin d2 receptors
04/01/2010US20100081671 Cycloalkylamine substituted isoquinoline derivatives
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
04/01/2010US20100081667 Chemical Compounds
04/01/2010US20100081660 Novel Compounds Having Selective Inhibiting Effect at GSK3
04/01/2010US20100081658 Heterocyclic antiviral compounds
04/01/2010US20100081657 Quinoxalines useful as inhibitors of protein kinases
04/01/2010US20100081656 Compositions and methods for modulating c-kit and pdgfr receptors
04/01/2010US20100081653 2-[1H-Benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
04/01/2010US20100081651 R(-)-11-hydroxyaporphine derivatives and uses thereof
04/01/2010US20100081646 Bicyclic heteroaryl inhibitors of pde4
04/01/2010US20100081643 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents
04/01/2010US20100081610 Matrix metalloproteinase inhibitors
04/01/2010US20100080786 Phenyl or Pyridinyl Substituted Indazoles Derivatives
04/01/2010US20100080758 Optical fluorescent imaging
04/01/2010US20100079066 Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Triazole Derivative
04/01/2010CA2738809A1 Quinazolinone, quinolone and related analogs as sirtuin modulators
04/01/2010CA2738448A1 New chemical compounds
04/01/2010CA2738236A1 Process for making quinolone compounds
04/01/2010CA2738083A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents
04/01/2010CA2737941A1 Selective seprase inhibitors
04/01/2010CA2737739A1 Heteroaryl antagonists of prostaglandin d2 receptors
04/01/2010CA2737694A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
04/01/2010CA2737384A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents
04/01/2010CA2736472A1 Pyrine or pyrazine derivatives for treating hcv
04/01/2010CA2736434A1 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
04/01/2010CA2735886A1 Indazole or 4,5,6,7-tetrahydro-indazole derivatives
04/01/2010CA2734472A1 2-[1h-benzimidazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
03/2010
03/31/2010EP2169028A2 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
03/31/2010EP2168960A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
03/31/2010EP2168959A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
03/31/2010EP2168958A1 Isoindole-Imide Compounds, Compositions And Uses Thereof
03/31/2010EP2168951A1 Azolylmethylenehydrazine derivative and use thereof
03/31/2010EP2168948A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
03/31/2010EP2168947A1 Novel compound having secretase inhibitory activity
03/31/2010EP2168576A2 New utilities of tricyclic compounds
03/31/2010EP2167492A2 Novel amide derivative for inhibiting the growth of cancer cells
03/31/2010EP2167490A1 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
03/31/2010EP2167489A2 Pyrimidine derivatives useful as raf kinase inhibitors
03/31/2010EP2167488A2 Process for preparing bepotastine and intermediates used therein
03/31/2010EP2167487A1 Pyrrole derivatives as p2y12 antagonists
03/31/2010EP2167484A2 Condensed anthranilamide insecticides
03/31/2010EP2167476A2 Novel hiv reverse transcriptase inhibitors
03/31/2010EP2167465A1 Indolinone derivatives and their use in treating disease-states such as cancer
03/31/2010EP2167092A2 Quinazoline derivatives as pi3 kinase inhibitors
03/31/2010EP2167083A2 Novel 1- heteroaryl-3-azabicycloý3.1.0¨hexanes, methods for their preparation and their use as medicaments
03/31/2010EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions
03/31/2010EP2166850A1 New heteocyclic h3 antagonists
03/31/2010EP2166849A1 Substituted pyrazole compounds
03/31/2010EP2076496B1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
03/31/2010EP1838697B1 Processes for preparing 4-(phenoxy-5-methyl-pyrimidin-4-yloxy)piperidine-1-carboxylic acid derivatives and related compounds
03/31/2010EP1756054B1 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
03/31/2010EP1675846B1 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h- [1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
03/31/2010EP1546107B1 Cox-2 inhibiting pyridine derivatives
03/31/2010EP1252139B1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
03/31/2010CN101687913A kallikrein 7 modulators
03/31/2010CN101687860A Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain